Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
Notified -
Globe Newswire8-10-2025, 18:09
Airnguru and Piano Launch Bundle and Ancillaries Price Optimization Engine with SKY Airline 1-08-2023, 20:10